Treatment of symptomatic hyperLp(a)lipidemia with LDL-apheresis vs. usual care

Transfusion and Apheresis Science

Volumn 42, Issue 1, 2010, Pages 21-26

  Stefanutti, C ^a   Vivenzio, A ^a   Di Giacomo, S ^a   Mazzarella, B ^a   Ferraro, P M ^b   Abbolito, S ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Coronary angiography; Coronary artery disease; HyperLp(a)lipoproteinemia; LDL apheresis

Indexed keywords

LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ANGIOGRAPHY; APHERESIS; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; HYPERLIPOPROTEINEMIA; INCIDENCE; LOW DENSITY LIPOPROTEIN APHERESIS; MALE; MEASUREMENT; REVASCULARIZATION;

ACRYLIC RESINS; ADULT; AGED; ANTICHOLESTEREMIC AGENTS; BLOOD COMPONENT REMOVAL; CHROMATOGRAPHY, AFFINITY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIET, FAT-RESTRICTED; EXERCISE THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERLIPOPROTEINEMIAS; INCIDENCE; LIPOPROTEIN(A); MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; RISK; TREATMENT OUTCOME;

EID: 76249103587     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2009.10.003     Document Type: Article

References (23)

1. Bewu A.D., and Durrington P.N. Lipoprotein (a): structure, properties and possible involvement in thrombogenesis and atherogenesis. Atherosclerosis 85 (1990) 1-14
2. Bostom A.G., et al. Lp(a): an independent CHD risk factor in men of the Framingham offspring cohort. JAMA 276 (1996) 544-548
3. Dahlen G.H., et al. Associations of levels of lipoprotein (a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 74 (1986) 758-764
4. Amstrong V.M., et al. The association between serum Lp(a) concentration and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis 62 (1986) 249-257
5. Crouse III J.R. New developments in the use of niacin for treatment of hyperlipidemia: new considerations in the use of an old drug. Coron Artery Dis 7 (1996) 321-326
6. Sirtori C.R., Calabresi L., Ferrara S., Pazzucconi F., Bondioli A., Baldassarre D., et al. L-Carnitine reduces plasma lipoprotein(a) levels in patients with hyper Lp(a). Nutr Metab Cardiovasc Dis 10 (2000) 247-251
7. Shewmon D.A., Stock J.L., Rosen C.J., Heiniluoma K.M., Hogue M.M., Morrison A., et al. Tamoxifen and estrogen lower circulating lipoprotein(a) concentrations in healthy postmenopausal women. Arterioscler Thromb 14 (1994) 1586-1593
8. Plenge J.K., Hernandez T.L., Weil K.M., Poirier P., Grunwald G.K., Marcovina S.M., et al. Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction. Circulation 106 12 (2002) 1447-1452
9. Dujovne C.A., Harris W.S., Altman R., Overhiser R.W., and Black D.M. Effect of atorvastatin on hemorheologic-hemostatic parameters and serum fibrinogen levels in hyperlipidemic patients. Am J Cardiol 85 (2000) 350-353
10. Cobbaert C., Jukema J.W., Zwinderman A.H., Withagen A.J., Lindemans J., and Bruschke A.V. Modulation of lipoprotein(a) atherogenicity by high density lipoprotein cholesterol levels in middle-aged men with symptomatic coronary artery disease and normal to moderately elevated serum cholesterol. Regression Growth Evaluation Statin Study (REGRESS) Study Group. J Am Coll Cardiol 30 (1997) 1491-1499
11. Duriez P., Dallongeville J., and Fruchart J.C. Lipoprotein(a) as a marker for coronary heart disease. Br J Clin Pract 77A (1996) 54-61
12. Gonbert S., Malinsky S., Sposito A.C., Laouenan H., Doucet C., Chapman M.J., et al. Atorvastatin lowers lipoprotein(a) but not apolipoprotein(a) fragment levels in hypercholesterolemic subjects at high cardiovascular risk. Atherosclerosis 48 (2002) 1454-1459
13. Akaike M., Azuma H., Kagawa A., Matsumoto K., Hayashi I., Tamura K., et al. Effect of aspirin treatment on serum concentrations of lipoprotein(a) in patients with atherosclerotic diseases. Clin Chem 48 (2002) 1454-1459
14. Jaeger B.R., Meiser B., Nagel D., et al. Aggressive lowering of fibrinogen and cholesterol in the prevention of graft vessel disease after heart transplantation. Circulation 96 9 Suppl. (1997) II-154-II-158
15. Dräger L.J., Julius U., Kraenzle K., et al. DALI - the first human whole blood low-density lipoprotein and lipoprotein (a) apheresis system in clinical use: procedure and clinical results. Eur J Clin Invest 28 (1998) 994-1002
16. Keller C. Indication of low-density lipoprotein apheresis in severe hypercholesterolemia and its vascular complications: dextran sulphate cellulose low-density lipoprotein apheresis. Ther Apher Dial 7 3 (2003) 345-349
17. Keller C. Apheresis in coronary heart disease with elevated Lp(a): a review of Lp(a) as a risk factor and its management. Ther Apher Dial 11 1 (2007) 2-8
18. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285(19):2486-97.
19. Schettler V., Wieland E., Armstrong V.W., et al. First steps toward the establishment of a German LDL-apheresis registry: recommendations for the indication and for quality management. Ther Apher 6 (2002) 381-383
20. Marcovina S.M., Koschinsky M.L., Albers J.J., and Skarlatos S. Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein (a) and cardiovascular disease: recent advances and future directions. Clin Chem 49 11 (2003) 1785-1796
21. Szczepiorkowski Z.M., Bandarenko N., and Kim H.C. Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 22 3 (2007) 106-175
22. Thompson G.R., and Kitano Y. The role of low density lipoprotein apheresis in the treatment of familial hypercholesterolemia. Ther Apher Dial 1 1 (2007) 13-16
23. Thompson G.R., and HEART-UK LDL Apheresis Working Group. Recommendations for the use of LDL apheresis. Atherosclerosis 198 2 (2008) 247-255